Lupin
Baricitinib Immunology & rheumatology
Originator: Olumiant · Eli Lilly and Company (co-developed with Incyte; initial U.S. approval 2018)
| Brand | Strength | Form |
|---|---|---|
| Barilup | 1 mg, 2 mg, 4 mg tablets | — |
Empagliflozin Diabetes & metabolic
Originator: Jardiance · Boehringer Ingelheim, co-marketed with Eli Lilly and Company (licensed from Boehringer Ingelheim International GmbH)
| Brand | Strength | Form |
|---|---|---|
| Gibtulio | 10 mg, 25 mg | — |
Linagliptin Diabetes & metabolic
Originator: Tradjenta · Boehringer Ingelheim (marketed in the US by Boehringer Ingelheim Pharmaceuticals, Inc.; co-promoted with Eli Lilly in several markets)
| Brand | Strength | Form |
|---|---|---|
| Ondero | 5 mg tablet | — |
Liraglutide Diabetes & metabolic
Originator: Victoza · Novo Nordisk
| Brand | Strength | Form |
|---|---|---|
| Liraglutide injection | 6 mg/mL | — |
Pioglitazone Diabetes & metabolic
Originator: Actos; Actoplus Met and Actoplus Met XR · Takeda Pharmaceutical Company (first US approval 1999)
| Brand | Strength | Form |
|---|---|---|
| Path | 15 mg, 30 mg, 45 mg | — |
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.
